Amanda Sheppeard

Daraxonrasib cut the risk of death by 60% and delivered the strongest late-stage results yet against metastatic pancreatic cancer, prompting emotional scenes at the world's largest cancer meeting.

The news has prompted calls for greater psychosocial support. New data released by the Leukaemia Foundation has laid bare the significant

AstraZeneca has yet to elaborate on its ‘commercial’ decision to discontinue a medication used by thousands of breast cancer and endometriosis patients.

Daraxonrasib cut the risk of death by 60% and delivered the strongest late-stage results yet against metastatic pancreatic cancer, prompting emotional scenes at the world's largest cancer meeting.

One Nation’s rise shows no sign of slowing, with a new reader poll revealing overwhelming support for Pauline Hanson and her insurgent party.

Three new reviews highlight advances in diagnosis, therapeutics, and sex-specific care that could transform outcomes in chronic kidney disease.

A phase 2 trial has found a myostatin inhibitor reduces lean mass loss in patients receiving tirzepatide.

Researchers have developed a novel dual-drug microneedle system that combines rapid itch relief with long-lasting anti-inflammatory and antimicrobial activity.

The RACGP is backing calls for greater scrutiny of proposed NDIS reforms, with GP leaders warning that support is being withdrawn before replacement services are ready.

A revised national stroke standard aims to improve life after hospital, with new expectations around rehabilitation, care plans and six-month reviews highlighting the important role of GPs in ongoing recovery.